Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
176.78
+1.14 (0.65%)
Nov 19, 2024, 3:44 PM EST - Market open
Krystal Biotech Employees
Krystal Biotech had 229 employees as of February 1, 2024. The number of employees increased by 19 or 9.05% compared to the previous year.
Employees
229
Change (1Y)
19
Growth (1Y)
9.05%
Revenue / Employee
$1,054,668
Profits / Employee
$228,699
Market Cap
5.08B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Feb 1, 2024 | 229 | 19 | 9.05% |
Feb 20, 2023 | 210 | 91 | 76.47% |
Feb 18, 2022 | 119 | 44 | 58.67% |
Feb 19, 2021 | 75 | 22 | 41.51% |
Feb 28, 2020 | 53 | 16 | 43.24% |
Feb 28, 2019 | 37 | 25 | 208.33% |
Jan 31, 2018 | 12 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Select Medical Holdings | 54,600 |
Stevanato Group | 5,634 |
Alkermes | 2,100 |
Waystar Holding | 1,400 |
Inspire Medical Systems | 1,011 |
PROCEPT BioRobotics | 626 |
Axsome Therapeutics | 545 |
Crinetics Pharmaceuticals | 290 |
KRYS News
- 13 days ago - Krystal Biotech to Present at Guggenheim Securities Healthcare Innovation Conference - GlobeNewsWire
- 15 days ago - Krystal Biotech, Inc. (KRYS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 22 days ago - Krystal Biotech to Report Third Quarter 2024 Financial Results on November 4, 2024 - GlobeNewsWire
- 5 weeks ago - Krystal Biotech: Q4 Catalysts Expected With VYJUVEK Revenue Growth Pressing On - Seeking Alpha
- 2 months ago - Krystal Biotech to Present at 2024 Cantor Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Krystal Biotech to Present at H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire
- 3 months ago - Krystal Biotech, Inc. (KRYS) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Krystal Biotech: High Valuation Merits Caution Ahead Of Q2 Earnings (Rating Downgrade) - Seeking Alpha